rs1343688414

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_002910.6(RENBP):​c.1270C>T​(p.Arg424*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000127 in 786,106 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 0.0000013 ( 0 hom. 0 hem. )

Consequence

RENBP
NM_002910.6 stop_gained

Scores

1
1
2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.57

Publications

0 publications found
Variant links:
Genes affected
RENBP (HGNC:9959): (renin binding protein) The gene product inhibits renin activity by forming a dimer with renin, a complex known as high molecular weight renin. The encoded protein contains a leucine zipper domain, which is essential for its dimerization with renin. The gene product can catalyze the interconversion of N-acetylglucosamine to N-acetylmannosamine, indicating that it is a GlcNAc 2-epimerase. Transcript variants utilizing alternative promoters have been described in the literature. [provided by RefSeq, Jul 2008]
NAA10 (HGNC:18704): (N-alpha-acetyltransferase 10, NatA catalytic subunit) N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
NAA10 Gene-Disease associations (from GenCC):
  • microphthalmia, syndromic 1
    Inheritance: XL, Unknown Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • NAA10-related syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: Broad Center for Mendelian Genomics, ClinGen, G2P
  • Ogden syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • microphthalmia, Lenz type
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002910.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RENBP
NM_002910.6
MANE Select
c.1270C>Tp.Arg424*
stop_gained
Exon 11 of 11NP_002901.2P51606-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RENBP
ENST00000393700.8
TSL:1 MANE Select
c.1270C>Tp.Arg424*
stop_gained
Exon 11 of 11ENSP00000377303.3P51606-1
RENBP
ENST00000875215.1
c.1396C>Tp.Arg466*
stop_gained
Exon 12 of 12ENSP00000545274.1
RENBP
ENST00000369997.7
TSL:5
c.1228C>Tp.Arg410*
stop_gained
Exon 11 of 11ENSP00000359014.3A6NKZ2

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD4 exome
AF:
0.00000127
AC:
1
AN:
786106
Hom.:
0
Cov.:
12
AF XY:
0.00
AC XY:
0
AN XY:
196130
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
16472
American (AMR)
AF:
0.00
AC:
0
AN:
10713
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
11750
East Asian (EAS)
AF:
0.00
AC:
0
AN:
22308
South Asian (SAS)
AF:
0.00
AC:
0
AN:
30390
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
26094
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2044
European-Non Finnish (NFE)
AF:
0.00000158
AC:
1
AN:
632132
Other (OTH)
AF:
0.00
AC:
0
AN:
34203
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
22

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.24
D
BayesDel_noAF
Uncertain
0.11
CADD
Uncertain
23
DANN
Benign
0.86
FATHMM_MKL
Benign
0.022
N
PhyloP100
-2.6
Vest4
0.48
GERP RS
-3.0
PromoterAI
-0.017
Neutral
Mutation Taster
=160/40
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1343688414; hg19: chrX-153200753; API